As peripheral reelin injections have been observed to rescue both central and peripheral alterations in depressive-like models, it may be postulated that reelin injections may mitigate or reverse ENS and microbiota dysfunction in depression, providing a novel therapeutic avenue that operates through mechanisms distinct from most currently used antidepressants. This evidence concerns the gene RELN and depressive symptom measurement.